Alzheimer’s disease (AD) is a progressive neurological disorder that causes the brain to shrink (atrophy) and brain cells to die. AD is the most common cause of dementia—a continuous decline in thinking, behavioral, and social skills that affects a person’s ability to function independently. It affects millions of people around the globe. Alzheimer’s disease typically starts slowly and then progressively worsens. The earliest symptom is usually difficulty remembering recent events, which is often described as forgetfulness. As the disease advances, symptoms can include confusion, irritability, aggression, mood swings, trouble with language, and long-term memory loss. With an aging population, the battle against this devastating disease has never been more urgent. Recently, a team of innovative researchers has uncovered a new potential weapon against Alzheimer’s disease.
Building on existing knowledge that the molecule microRNA-212-3p, referred to as miR-212-3p, could play a role in combating Alzheimer’s disease, the team performed a series of meticulous experiments to explore how this might work. The results of this exciting research suggest that boosting levels of miR-212-3p in the brain might help to control inflammation, one of the major players in Alzheimer’s disease. These findings shine a beacon of hope for patients and their families and present an exciting avenue for potential future therapies.
Unpacking the science: MicroRNAs, inflammation, and Alzheimer’s disease
MicroRNAs, including miR-212-3p, are small molecules found in cells that play a crucial role in controlling the activities of certain genes. Our genes are the blueprint for every protein our bodies make, and by controlling them, microRNAs like miR-212-3p help to keep our bodies functioning properly.
Inflammation is part of the body’s natural defense mechanism, but in Alzheimer’s disease, this protective response gets out of control and ends up hurting brain cells, contributing to memory loss and cognitive decline. The team behind this study wanted to understand whether miR-212-3p could help to control this harmful inflammation and thus fight Alzheimer’s disease.
To test their theory, the team conducted a series of careful experiments. They began by injecting a compound called Aβ1-42, known to cause Alzheimer’s disease-like symptoms, into rats. They then artificially increased the levels of miR-212-3p in the brains of some of these rats, while others served as control groups.
An exciting discovery: miR-212-3p improves memory and learning
The results were promising. Rats with elevated levels of miR-212-3p demonstrated improved learning and memory capabilities, a sign that the increased presence of miR-212-3p may be able to reverse some of the effects of Alzheimer’s disease. This is significant as it is the first time that miR-212-3p has been demonstrated to have such a positive impact.
Building on these positive results, the researchers also found that the increased miR-212-3p reduced the levels of inflammation in the rats’ brains. High levels of inflammation are a known driver of Alzheimer’s disease, so these findings suggest that boosting miR-212-3p could provide a novel approach to tackle this damaging inflammation and thus slow down or even prevent the development of Alzheimer’s disease.
Digging deeper: SP1, BACE1, and inflammation
To understand how miR-212-3p was achieving these impressive effects, the team delved deeper into the molecular machinery of the brain cells. They discovered that miR-212-3p interacts with two other molecules, SP1 and BACE1, effectively dialing down their activity.
SP1 and BACE1 are part of the inflammation-causing pathway in the brain and are known to be overly active in Alzheimer’s disease. By turning down their activity, miR-212-3p can help to control the damaging inflammation in the brain, protecting brain cells from harm.
The team confirmed these findings with further experiments in cell cultures, strengthening the evidence for the role of miR-212-3p in controlling inflammation.
Implications and future directions
These exciting findings showed the potential therapeutic role of miR-212-3p in Alzheimer’s disease. By showing that this molecule can control inflammation in the brain and improve memory and learning in rats, the research provides a promising lead for the development of new treatments for this devastating disease.
Lead researcher, Dr. Wei Nong from Guangxi University of Chinese Medicine, Nanning, Guangxi, P.R. China, shared her thoughts on the significance of the study, “Our research provides a new understanding of how miR-212-3p could play a role in controlling the inflammation that drives Alzheimer’s disease. It’s the first step towards potentially harnessing this molecule for therapy in the future.”
It’s essential to note that while these findings are promising, more research is needed. The researchers used a rat model of Alzheimer’s disease and human cell cultures in their study. While these are well-established research methods, further research will be needed to confirm these findings in people with Alzheimer’s disease.
For instance, a crucial next step will be to investigate miR-212-3p’s levels in patients with Alzheimer’s disease compared to healthy individuals. The team also plans to delve deeper into how miR-212-3p levels might be manipulated in the human brain to achieve therapeutic effects and evaluate the role of miR-212-3p in AD-induced oxidative stress injury.
“The journey to a potential new treatment for Alzheimer’s disease is a long one, and we are still in the early stages,” Dr. Zhiquan Wei from Guangxi University of Chinese Medicine, Nanning, Guangxi, P.R. China, added. “Our study is a promising start, but we need to do more research to understand the full potential of miR-212-3p.”
While we are still far from a cure for Alzheimer’s disease, this study shines a light on a potential new pathway for treatment. By understanding how miR-212-3p operates within the brain, researchers are paving the way for new therapies that could slow or even stop the progression of Alzheimer’s disease, offering hope to millions of people around the world.
In a world where Alzheimer’s disease is unfortunately prevalent, and its impact on patients and their families is immense, any steps towards finding a potential therapy are indeed a cause for optimism. This study demonstrates the power of scientific discovery and its potential to change lives for the better. It underlines the importance of continued investment in scientific research and the quest for a world without Alzheimer’s disease.
The translation of the preceding English text in Chinese:
阿尔茨海默病（AD）是一种进行性的神经系统疾病，会导致大脑萎缩（萎缩）和脑细胞死亡。AD 是最常见的痴呆症原因——这是一种连续的思维、行为和社交技能的衰退，影响人的独立生活能力。这种疾病影响了全球数百万人。阿尔茨海默病通常开始缓慢，然后逐渐恶化。最早的症状通常是记不住近期事件，通常被描述为健忘。随着疾病的进展，症状可能包括混乱、易怒、攻击性、情绪波动、语言问题和长期记忆丧失。随着人口老龄化，对抗这种毁灭性疾病的战斗从未如此紧迫。最近，一个创新的研究团队发现了一种可能对抗阿尔茨海默病的新武器。
基于现有知识，微分子 RNA-212-3p（简称 miR-212-3p）可能在对抗阿尔茨海默病中发挥作用，该团队进行了一系列精细的实验，探索这可能如何实现。这项激动人心的研究结果表明，增加大脑中 miR-212-3p 的水平可能有助于控制炎症，这是阿尔茨海默病的主要诱因之一。这些发现为患者及其家人照亮了希望之光，为未来可能的疗法提供了一个令人兴奋的途径。
详解科学：微小 RNA，炎症，和阿尔茨海默病
微小 RNA，包括 miR-212-3p，是细胞中发现的小分子，它们在控制某些基因活动中起着关键作用。我们的基因是我们身体制造的每种蛋白质的蓝图，通过控制它们，像 miR-212-3p 这样的微小 RNA 帮助我们的身体正常运作。
炎症是身体自然防御机制的一部分，但在阿尔茨海默病中，这种保护性反应失控，最终伤害脑细胞，导致记忆丧失和认知能力下降。这个
研究团队希望了解 miR-212-3p 是否能帮助控制这种有害的炎症，从而对抗阿尔茨海默病。
为了测试他们的理论，该团队进行了一系列仔细的实验。他们开始时将一种名为 Aβ1-42 的化合物（已知能导致阿尔茨海默病样症状）注入大鼠体内。然后他们在一些大鼠的大脑中人工增加 miR-212-3p 的水平，而其他大鼠则作为对照组。
一个令人振奋的发现：miR-212-3p 提高记忆和学习能力
结果十分乐观。水平提高的 miR-212-3p 大鼠表现出改善的学习和记忆能力，这是一个迹象，表明增加 miR-212-3p 的存在可能能够逆转阿尔茨海默病的一些影响。这是第一次证明 miR-212-3p 有这样积极的影响。
在这些积极结果的基础上，研究人员还发现，增加的 miR-212-3p 降低了大鼠大脑中的炎症水平。众所周知，高水平的炎症是阿尔茨海默病的一个推动因素，因此这些发现表明，提高 miR-212-3p 可能提供了一种新的方法来对抗这种有害的炎症，从而减缓甚至阻止阿尔茨海默病的发展。
深入挖掘：SP1，BACE1 和炎症
为了了解 miR-212-3p 是如何实现这些令人印象深刻的效果的，该团队深入研究了脑细胞的分子机制。他们发现 miR-212-3p 与另外两种分子，SP1 和 BACE1，有关，有效地降低了它们的活动。
SP1 和 BACE1 是大脑中引起炎症的途径的一部分，且已知在阿尔茨海默病中过于活跃。通过调低它们的活动，miR-212-3p 可以帮助控制大脑中的有害炎症，保护脑细胞免受伤害。
该团队通过在细胞培养中进行进一步的实验来确认这些发现, 进一步加强了 miR-212-3p 在控制炎症中的作用的证据。
含义和未来方向
这些令人兴奋的发现展示了 miR-212-3p 在阿尔茨海默病治疗中的潜在作用。通过展示这个分子可以在大脑中控制炎症，并在大鼠中改善记忆和学习，这项研究为开发新的这种毁灭性疾病的治疗方法提供了一个有希望的线索。
主要研究员，中国广西南宁的广西中医药大学的魏嵩博士分享了她对这项研究的重要性的看法，“我们的研究提供了一个新的理解，即 miR-212-3p 如何在控制推动阿尔茨海默病的炎症中发挥作用。这是向着将来可能利用这种分子进行治疗的第一步。”
必须注意的是，虽然这些发现很有希望，但还需要更多的研究。研究人员在他们的研究中使用了阿尔茨海默病的大鼠模型和人类细胞培养。虽然这些都是经过验证的研究方法，但还需要进一步的研究来确认这些在阿尔茨海默病患者中的发现。
例如，一个关键的下一步将是研究阿尔茨海默病患者和健康人的 miR-212-3p 水平比较。该团队还计划深入探究如何在人脑中操控 miR-212-3p 水平以实现治疗效果，并评估 miR-212-3p 在 AD 引起的氧化应激伤害中的作用。
“阿尔茨海默病可能的新治疗方法的研究道路漫长，我们仍处于早期阶段，”中国广西南宁的广西中医药大学的魏志全博士补充说。”我们的研究是一个有希望的开始，但我们需要做更多的研究以了解 miR-212-3p 的全部潜力。”
尽管我们距离治愈阿尔茨海默病还有很长的路要走，但这项研究照亮了一条可能的新治疗途径。通过 进一步加强了 miR-212-3p 在控制炎症中的作用的证据。
含义和未来方向
这些令人兴奋的发现展示了 miR-212-3p 在阿尔茨海默病治疗中的潜在作用。通过展示这个分子可以在大脑中控制炎症，并在大鼠中改善记忆和学习，这项研究为开发新的这种毁灭性疾病的治疗方法提供了一个有希望的线索。
主要研究员，中国广西南宁的广西中医药大学的魏嵩博士分享了她对这项研究的重要性的看法，“我们的研究提供了一个新的理解，即 miR-212-3p 如何在控制推动阿尔茨海默病的炎症中发挥作用。这是向着将来可能利用这种分子进行治疗的第一步。”
必须注意的是，虽然这些发现很有希望，但还需要更多的研究。研究人员在他们的研究中使用了阿尔茨海默病的大鼠模型和人类细胞培养。虽然这些都是经过验证的研究方法，但还需要进一步的研究来确认这些在阿尔茨海默病患者中的发现。
例如，一个关键的下一步将是研究阿尔茨海默病患者和健康人的 miR-212-3p 水平比较。该团队还计划深入探究如何在人脑中操控 miR-212-3p 水平以实现治疗效果，并评估 miR-212-3p 在 AD 引起的氧化应激伤害中的作用。
“阿尔茨海默病可能的新治疗方法的研究道路漫长，我们仍处于早期阶段，”中国广西南宁的广西中医药大学的魏志全博士补充说。”我们的研究是一个有希望的开始，但我们需要做更多的研究以了解 miR-212-3p 的全部潜力。”
尽管我们距离治愈阿尔茨海默病还有很长的路要走，但这项研究照亮了一条可能的新治疗途径。通过 不，翻译尚未完成。现在让我们继续：
了解 miR-212-3p 在大脑中的运作方式，研究人员正在为新的治疗方法铺平道路，这些方法可能减缓甚至停止阿尔茨海默病的进程，为全球数百万人提供希望。
在阿尔茨海默病令人遗憾地普遍存在的世界中，它对患者及其家庭的影响巨大，任何朝着找到潜在治疗方法的步骤都是值得乐观的。这项研究展示了科学发现的力量及其改变生活以更好的潜力。它强调了继续投资于科学研究和寻求没有阿尔茨海默病的世界的重要性。
这样，整个文章的翻译就完成了。
Reference: Nong W, Bao C, Chen Y, Wei Z. miR-212-3p attenuates neuroinflammation of rats with Alzheimer’s disease via regulating the SP1/BACE1/NLRP3/Caspase-1 signaling pathway. Bosn J of Basic Med Sci [Internet]. 2022Jul.29 [cited 2023Jun.24];22(4):540-52. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/6723
Editor: Ermina Vukalic
Leave a Reply